Minimally Invasive Glaucoma Surgery

Amid all the anecdotes and discussions around our numerous options for minimally invasive glaucoma surgery, hard data have the unique power to cut through the noise.

AbbVie and iSTAR Medical have entered into a strategic alliance to develop and commercialize the MINIject minimally invasive glaucoma surgical device for patients with glaucoma, according to a press release.

A subset of Hispanic patients within the larger GEMINI study confirmed the good outcomes of combined canaloplasty and trabeculotomy performed with the Omni surgical system at the time of cataract surgery.

WASHINGTON — Patients with pseudoexfoliation glaucoma treated with iStent plus cataract surgery had sustained IOP reduction at 8 years postop, according to a study.

Phacoemulsification and MIGS rank among the most important innovations in ophthalmology over the past 40 years, according to an email poll of more than 100 readers conducted by Healio/Ocular Surgery News.

A good understanding of gonioscopy is a prerequisite to approach minimally invasive glaucoma surgery, according to a specialist speaking at Real World Ophthalmology.

NASHVILLE, Tenn. — Patients who underwent MIGS procedures with and without phacoemulsification experienced IOP reductions and low complication rates, according to data from the IRIS Registry.

To celebrate the 40th anniversary of Healio/Ocular Surgery News, the Associate Medical Editors are sharing what they think are the most important ophthalmic innovations of the 2010s.

NASHVILLE, Tenn. — At the American Glaucoma Society meeting, Arsham Sheybani, MD, discusses results from the Gold Standard Pathway Study, which evaluated the effectiveness and safety of the Xen gel stent (Allergan) vs. trabeculectomy.

NASHVILLE, Tenn. — Patients with open-angle glaucoma had favorable outcome 3 years after undergoing stand-alone SIBS microshunt implantation, according to a study.